Genomic Answers for Children’s Health Act of 2026

Summary

The Genomic Answers for Children’s Health Act would require Medicaid to pay for whole genome and whole exome sequencing when used as a first‑tier test for children suspected of genetic disorders, rare diseases, or unexplained health conditions. It defines the tests, separates their payment from other services, and orders the Health Secretary to educate providers and report on use and outcomes. The goal is to improve diagnosis and treatment for vulnerable children.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share